A Phase 3 interventional study of Kyphoplasty in Osteoporotic Vertebral Compression Fractures, sponsored by University of Virginia. Completed at 1 site in United States. Open to participants aged 50 Years to 100 Years. Per ClinicalTrials.gov, last updated 2016-08-18.
Sponsored by University of Virginia · Phase 3, Interventional, and Treatment
Randomized trial comparing cost effectiveness and efficacy of kyphoplasty vs vertebroplasty for the treatment of painful, osteoporotic vertebral compression fractures.
50 studies on the registry are indexed under Fractures, Compression; 10 are open to participants now.
This study's enrollment of 112 is above the median of 73 across 32 interventional studies indexed under Fractures, Compression.
Browse Fractures, Compression studies →University of Virginia is the lead sponsor of 675 studies on the registry; 138 are open to participants now.
Of its 61 completed or terminated interventional studies of FDA-regulated products, 42 (69%) have results posted.
Counted across the registry records on this site, refreshed daily.
vertebroplasty
Procedure: Kyphoplasty
kyphoplasty
Procedure: Kyphoplasty
kyphoplasty
Back specific functional status(Roland)
Time frame: 12 mo
Pain
Time frame: 12 mo
Health status outcome measure(SF-36)
Time frame: 12 mo
The record gives a start of May 2005, a primary completion of Sep 2011 and a completion of Sep 2011. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.